Trader Joe’s Triple Ginger Brew Recall Issued After Reports of Bottles Bursting
Government health officials have issued a recall for all Trader Joe’s Triple Ginger Brew glass bottles, after several consumer complaints indicated that unopened bottles shattered or burst, posing a potential laceration and injury hazard for consumers.
The Trader Joe’s Triple Ginger Brew recall was announced by the FDA on December 15, following problems where unopened bottles shattered and burst open without any tampering or mishandling of the glass bottles. To date, no injuries have been reported.
According to a press release by Trader Joe’s, the Triple Ginger Brew beverage does not contain any adverse health contaminates nor is it unsafe to drink. The recall was issued solely due to a potential defect with the glass bottles the beverage is sold in.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
Customers are being asked to handle the products with extreme caution and throw them away. Shattering or breaking glass bottles could pose serious laceration hazards to consumers and those nearby.
The recall includes Trader Joe’s Triple Ginger Brew sodas sold in 25.4 FL ounce glass bottles with SKU number 51857. The beverages were distributed to Trader Joe’s stores where they were sold on store shelves nationwide from November 9, to December 14, 2015.
According to Trader Joe’s announcement, all impacted Triple Ginger Brew products have been removed from store shelves and destroyed.
Customers are being asked to handle to product with care and dispose of them in an outside container. Trader Joe’s announced it will provide a full refund for any customer who purchased the recalled products at any of their Trader Joe’s stores. For further questions and concerns, customers may contact the company’s Customer Relations at 626-599-3817.
"*" indicates required fields
More Top Stories
A new report indicates the U.S. Navy is struggling to process tens of thousands of Camp Lejeune water poisoning claims due to a lack of resources.
A group of plaintiffs have filed a motion with the U.S. JPML seeking consolidation of all Bard implanted port lawsuits before one judge for pretrial proceedings.
A Tepezza hearing loss lawsuit accuses the manufacturer of failing to provide adequate warning about the risks of the thyroid eye disease drug.